A short expert video (Robert Whitfield MD) discussing clinical risks of breast implants — especially infections and implant loss in patients receiving chemotherapy — and clinical counseling: for small increases (about one cup size) he prefers fat transfer over implants because the implant risk–benefit ratio may not make sense in that scenario.
And because we did all these other surgeries with all those other adjuvant treatments for cancer patients, I was always getting called, hey, you know, Mrs. Smith has red breasts now. She's being admitted for IV antibiotics in 24 hours. If she's not better, we're gonna have to take out her implant. I mean, that was a. That would happen when people were on chemotherapy. Yeah. So I come into your. Your office five years ago, and I'm interested. What are. What are the risks for me stepping into the implant space? Yeah. So I would have been, you know, if somebody only wants to go up a cup size, I would explain, you know, fat transfers to them. And then I would say, the risk benefit ratio for an implant doesn't make sense.
